Cardiovascular Engineering and Technology

, Volume 2, Issue 3, pp 149–159

Rapid Engineered Small Diameter Vascular Grafts from Smooth Muscle Cells

  • Wei He
  • Alejandro Nieponice
  • Yi Hong
  • William R. Wagner
  • David A. Vorp


Smooth muscle cells (SMCs) have been extensively used as components in tissue engineered vascular grafts (TEVGs) due to their important roles in vasoactivity and blood vessel remodeling. For TEVG approaches that rely on SMC seeding of a scaffold prior to implantation, few if any utilize a highly-efficient bulk-seeding process to achieve densely and uniformly distributed cells. The objective of this study was to assess a TEVG based on a biodegradable tubular scaffold bulk-seeded with SMCs and cultured acutely in vitro. Rat SMCs were seeded into bi-layered poly(ester-urethane)urea (PEUU) scaffolds using a customized rotational vacuum seeding device. The seeded constructs were dynamically cultured in spinner flasks for 2 days and then implanted into Lewis rats as aortic interposition grafts for 8 weeks. Results showed rSMCs populated the porous layer of the constructs evenly and densely immediately after seeding. The seeding and dynamic culture processes did not affect the metabolic activity and phenotype of the rSMCs. After implantation, rSMC-seeded TEVGs showed a higher patency rate than the unseeded control (75% vs. 37.5% respectively). Patent rSMC-seeded TEVGs revealed extensive tissue remodeling consisting of multiple layers of α-smooth muscle actin- and calponin-positive cells, and a von Willebrand factor-positive monolayer lining the lumen. These results demonstrate the feasibility of quick fabrication of a SMC-based TEVG in vitro and suggest that the cells play a role in maintaining patency of the TEVG as an arterial conduit.


Tissue engineering Vascular graft Smooth muscle cell Seeding device Scaffold Animal model 


  1. 1.
    Bergman, R. M., and R. M. Nerem. The cardiovascular technology industry: past, present, and future. Cardiovasc. Eng. Technol. 1:4–9, 2010.CrossRefGoogle Scholar
  2. 2.
    FastStats. Inpatient Surgery. [Web Site] 2003 November 14 [cited 2003 November 22]; Available from:
  3. 3.
    Guan, J., et al. Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine. J. Biomed. Mater. Res. 61:493–503, 2002.CrossRefGoogle Scholar
  4. 4.
    Hashi, C. K., et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc. Natl Acad. Sci. 104:11915–11920, 2007.CrossRefGoogle Scholar
  5. 5.
    He, W., et al. Pericyte-based human tissue engineered vascular grafts. Biomaterials 31:8235–8244, 2010.CrossRefGoogle Scholar
  6. 6.
    Hibino N, et al., Late-term results of tissue-engineered vascular grafts in humans. J. Thorac. Cardiovasc. Surg. 139:431–6, 436 e1–2, 2010.Google Scholar
  7. 7.
    Isenberg, B. C., C. Williams, and R. T. Tranquillo. Small-diameter artificial arteries engineered in vitro. Circ. Res. 98:25–35, 2006.CrossRefGoogle Scholar
  8. 8.
    Kurpinski, K., et al. Regulation of vascular smooth muscle cells and mesenchymal stem cells by mechanical strain. Mol. Cell. Biomech. 3:21–34, 2006.MATHGoogle Scholar
  9. 9.
    L’Heureux, N., et al. A completely biological tissue-engineered human blood vessel. FASEB J. 12:47–56, 1998.Google Scholar
  10. 10.
    Lloyd-Jones, D., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:480–486, 2009.CrossRefGoogle Scholar
  11. 11.
    Maul T. Mechanobiology of stem cells: implications for vascular tissue engineering. In: Bioengineering. 2007. Pittsburgh: University of Pittsburgh, p. 345.Google Scholar
  12. 12.
    McAllister, T. N., et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373:1440–1446, 2009.CrossRefGoogle Scholar
  13. 13.
    Nalysnyk, L., et al. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart 89:767–772, 2003.CrossRefGoogle Scholar
  14. 14.
    Nerem, R. M., and D. Seliktar. Vascular tissue engineering. Annu. Rev. Biomed. Eng. 3:225–243, 2001.CrossRefGoogle Scholar
  15. 15.
    Nieponice, A., et al. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng. A. 16:1215–1223, 2010.CrossRefGoogle Scholar
  16. 16.
    Niklason, L. E., et al. Functional arteries grown in vitro. Science 284:489–493, 1999.CrossRefGoogle Scholar
  17. 17.
    O’Callaghan, C. J., and B. Williams. Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells—role of TGF-beta(1). Hypertension 36:319–324, 2000.Google Scholar
  18. 18.
    Owens, G. K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487–517, 1995.Google Scholar
  19. 19.
    Ray, J. L., et al. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 23:185–188, 2001.CrossRefGoogle Scholar
  20. 20.
    Reusch, P., et al. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ. Res. 79:1046–1053, 1996.Google Scholar
  21. 21.
    Roh, J. D., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc. Natl Acad. Sci. 107:4669–4674, 2010.CrossRefGoogle Scholar
  22. 22.
    Soletti, L., et al. A seeding device for tissue engineered tubular structures. Biomaterials 27:4863–4870, 2006.CrossRefGoogle Scholar
  23. 23.
    Soletti, L., et al. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater. 6:110–122, 2010.CrossRefGoogle Scholar
  24. 24.
    Stegemann, J. P., and R. M. Nerem. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann. Biomed. Eng. 31:391–402, 2003.CrossRefGoogle Scholar
  25. 25.
    Stegemann, J. P., H. Hong, and R. M. Nerem. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J. Appl. Physiol. 98:2321–2327, 2005.CrossRefGoogle Scholar
  26. 26.
    Thyberg, J. Phenotypic: Modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol. Histopathol. 13:871–891, 1998.Google Scholar
  27. 27.
    Thyberg, J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int. Rev. Cytol. Survey Cell Biol. 169:183–265, 1996.Google Scholar
  28. 28.
    WHO. Fact sheet No. 317: cardiovascular diseases. 2010 September 2009 [cited 2010 September 17th]; Available from:
  29. 29.
    Xue, L., and H. P. Greisler. Biomaterials in the development and future of vascular grafts. J. Vasc. Surg. 37:472–480, 2003.CrossRefGoogle Scholar

Copyright information

© Biomedical Engineering Society 2011

Authors and Affiliations

  • Wei He
    • 1
    • 3
    • 4
    • 5
  • Alejandro Nieponice
    • 1
    • 4
    • 5
  • Yi Hong
    • 1
    • 4
    • 5
  • William R. Wagner
    • 1
    • 2
    • 4
    • 5
  • David A. Vorp
    • 1
    • 2
    • 3
    • 4
    • 5
  1. 1.Department of SurgeryUniversity of PittsburghPittsburghUSA
  2. 2.Department of BioengineeringUniversity of PittsburghPittsburghUSA
  3. 3.Department of Cardiothoracic SurgeryUniversity of Pittsburgh Medical CenterPittsburghUSA
  4. 4.McGowan Institute for Regenerative MedicinePittsburghUSA
  5. 5.Center for Vascular Remodeling and RegenerationUniversity of PittsburghPittsburghUSA

Personalised recommendations